MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Laetitia Lambros; Arnaud Uguen

doi:10.1016/j.cllc.2018.12.002

Journal articles

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Laetitia Lambros ¹ Arnaud Uguen ^{1, 2}

1 CHU - AnaPath - CHRU Brest - Laboratoire d'Anatomo-Pathologie

2 LBAI - Lymphocyte B et Auto-immunité

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Immunology

Complete list of metadata

https://hal.univ-brest.fr/hal-02262486
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Friday, August 2, 2019 - 3:35:52 PM
Last modification on : Wednesday, November 3, 2021 - 7:53:52 AM

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Identifiers

Collections

Citation

Export

Metrics

42

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Identifiers

Collections

Citation

Export

Share

Metrics

42